Details for: VIIBRYD
Company: ALLERGAN INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02443724 | VIIBRYD | VILAZODONE HYDROCHLORIDE | 10 MG | TABLET | ORAL |
| 02443732 | VIIBRYD | VILAZODONE HYDROCHLORIDE | 20 MG | TABLET | ORAL |
| 02443759 | VIIBRYD | VILAZODONE HYDROCHLORIDE; VILAZODONE HYDROCHLORIDE | 10 MG; 20 MG | TABLET | ORAL |
| 02443759 | VIIBRYD | VILAZODONE HYDROCHLORIDE; VILAZODONE HYDROCHLORIDE | 10 MG; 20 MG | KIT | ORAL |
| 02443740 | VIIBRYD | VILAZODONE HYDROCHLORIDE | 40 MG | TABLET | ORAL |
Summary Reports
Summary Basis of Decision
Regulatory Decision Summary
Regulatory Decision Summary
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-norepinephrine Reuptake Inhibitors (SNRIs) - Assessing the Potential Risk of Sexual Dysfunction despite Treatment Discontinuation
Regulatory Decision Summary
Regulatory Decision Summary
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-norepinephrine Reuptake Inhibitors (SNRIs) - Assessing the Potential Risk of Sexual Dysfunction despite Treatment Discontinuation
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.